Small Interfering RNA Market: How Is RNAi Therapeutics Transforming Gene Silencing Medicine?
Small interfering RNA therapeutics — the double-stranded RNA molecules of approximately twenty-one to twenty-three nucleotides that trigger RNA interference silencing specific disease-causing genes through the RISC (RNA-induced silencing complex) pathway — represent one of the most transformative pharmaceutical modalities in modern medicine, with the Small Interfering RNA Market...
0 Yorumlar 0 hisse senetleri 21 Views 0 önizleme